The tumour–stroma ratio (TSR) is emerging as a robust, cost‐effective histopathological parameter that quantifies the relative proportion of neoplastic cells to the surrounding stromal tissue.

Researchers at the Cancer Research Institute and the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have ...

The stroma to tumor ratio potentially identifies higher risk bladder cancer tumors and might help guide immunotherapy. Bladder tumors with higher stromal content may have a more immunosuppressive ...

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer. Discovery of a subset of high-risk progenitor cells that reside in fallopian tube ...

A recent study found that tumor-stroma proportion was a reliable marker of chemoresistance, progression-free survival, and overall survival in high-grade serous ovarian cancer. TSP, which assesses the ...

—In this study, molecular classification of endometrial cancer with cervical stromal invasion was associated with recurrence-free survival by univariate analysis. But after controlling for tumor stage ...

Researchers at the Cancer Research Institute and the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have uncovered a critical mechanism that enables gastric cancer to spread to ...

About 1,200 Germans are diagnosed with gastrointestinal stromal tumors every year—a rare type of cancer in which the tumors develop in the walls of the digestive organs and quickly develop resistance ...